About 2,300 results
PipelineReview.com. Biopharmaceutical News & Clinical Trials
All news - Pipelinereview
GSK Announces Positive Topline Data on Co-Administration of …
I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus …
Fasenra approved in the US for eosinophilic granulomatosis with ...
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
Ten-Year Data for Merck’s KEYTRUDA® (pembrolizumab) …
RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE
European Commission Approves Astellas' PADCEV™ (enfortumab …